Ikarian Capital, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 138 filers reported holding CARA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$418,000
-98.6%
29,335
-97.9%
0.03%
-96.7%
Q1 2021$30,504,000
+250.5%
1,405,124
+144.3%
1.03%
+168.1%
Q4 2020$8,702,000
+106.3%
575,224
+73.5%
0.38%
+25.6%
Q3 2020$4,219,000
-15.8%
331,524
+13.1%
0.30%
-23.6%
Q2 2020$5,012,000
-33.6%
293,124
-48.7%
0.40%
-29.8%
Q1 2020$7,553,000
+2039.7%
571,763
+2510.8%
0.57%
+896.5%
Q4 2019$353,00021,9000.06%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,568,057$70,005,00074.08%
Chescapmanager LLC 1,203,055$23,604,0002.80%
Mesirow Financial Investment Management, Inc. 29,821$585,0002.32%
DAFNA Capital Management LLC 143,611$2,818,0001.22%
Opaleye Management Inc. 200,000$3,924,0001.09%
SPHERA FUNDS MANAGEMENT LTD. 303,930$5,963,0000.54%
DISCIPLINED GROWTH INVESTORS INC /MN 852,892$16,734,0000.29%
DLD Asset Management, LP 352,700$6,927,0000.26%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 54,984$1,079,0000.18%
B. Riley Wealth Management, Inc. 33,755$662,0000.12%
View complete list of CARA THERAPEUTICS INC shareholders